Blueprint Investment Partners LLC Vertex Pharmaceuticals Inc Transaction History

Blueprint Investment Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$338.18 - $362.46 $74,737 - $80,103	-221 Reduced 25.88%	633 $220,000
Q2 2023 Aug 15, 2023	BUY	$314.42 - $351.91 $268,514 - $300,531	854 New	854 $300,000
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $35,871 - $40,024	-131 Reduced 12.58%	910 $263,000
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $19,031 - $23,696	81 Added 8.44%	1,041 $293,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $63,326 - $74,637	286 Added 42.43%	960 $251,000
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $119,304 - $150,605	674 New	674 $148,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.